These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F. Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217 [Abstract] [Full Text] [Related]
3. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. J Neuropathol Exp Neurol; 2012 Jul; 71(7):604-17. PubMed ID: 22710964 [Abstract] [Full Text] [Related]
4. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab. Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D. JAMA Neurol; 2013 Mar 01; 70(3):398-402. PubMed ID: 23338729 [Abstract] [Full Text] [Related]
8. [Differential diagnosis of immune reconstitution inflammatory syndrome and progressive multifocal leukoencephalopathy after natalizumab withdrawal]. Yakushina TI, Yakushin DM, Shtang IO. Zh Nevrol Psikhiatr Im S S Korsakova; 2023 Apr 01; 123(3):116-121. PubMed ID: 36946407 [Abstract] [Full Text] [Related]
9. Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy. Tan LA, Lopes DK. J Clin Neurosci; 2015 Oct 01; 22(10):1669-71. PubMed ID: 26115897 [Abstract] [Full Text] [Related]
10. Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients. Dahlhaus S, Hoepner R, Chan A, Kleiter I, Adams O, Lukas C, Hellwig K, Gold R. J Neurol Neurosurg Psychiatry; 2013 Oct 01; 84(10):1068-74. PubMed ID: 23606731 [Abstract] [Full Text] [Related]
11. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, Häusler D, Brück W. Acta Neuropathol; 2012 Feb 01; 123(2):235-45. PubMed ID: 22057786 [Abstract] [Full Text] [Related]
12. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient. Krey L, Raab P, Sherzay R, Berding G, Stoll M, Stangel M, Wegner F. Front Immunol; 2019 Feb 01; 10():1188. PubMed ID: 31191548 [Abstract] [Full Text] [Related]
13. Progressive multifocal leukoencephalopathy and JC Virus-related disease in modern neurology practice. Carruthers RL, Berger J. Mult Scler Relat Disord; 2014 Jul 01; 3(4):419-30. PubMed ID: 25877052 [Abstract] [Full Text] [Related]
14. Review of progressive multifocal leukoencephalopathy and natalizumab. Aksamit AJ. Neurologist; 2006 Nov 01; 12(6):293-8. PubMed ID: 17122725 [Abstract] [Full Text] [Related]
15. Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy. Hodel J, Bapst B, Outteryck O, Verclytte S, Deramecourt V, Benadjaoud MA, Pruvo JP, Vermersch P, Leclerc X. Mult Scler; 2018 Dec 01; 24(14):1902-1908. PubMed ID: 29343163 [Abstract] [Full Text] [Related]
16. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A. Neurology; 2011 Sep 13; 77(11):1061-7. PubMed ID: 21832229 [Abstract] [Full Text] [Related]